Correlation Between Kiora Pharmaceuticals and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Immix Biopharma, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Immix Biopharma.
Diversification Opportunities for Kiora Pharmaceuticals and Immix Biopharma
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Kiora and Immix is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Immix Biopharma go up and down completely randomly.
Pair Corralation between Kiora Pharmaceuticals and Immix Biopharma
Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to under-perform the Immix Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Kiora Pharmaceuticals is 2.08 times less risky than Immix Biopharma. The stock trades about -0.28 of its potential returns per unit of risk. The Immix Biopharma is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 164.00 in Immix Biopharma on January 10, 2025 and sell it today you would lose (17.70) from holding Immix Biopharma or give up 10.79% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kiora Pharmaceuticals vs. Immix Biopharma
Performance |
| Timeline |
| Kiora Pharmaceuticals |
| Immix Biopharma |
Kiora Pharmaceuticals and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiora Pharmaceuticals and Immix Biopharma
The main advantage of trading using opposite Kiora Pharmaceuticals and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |